iA Global Asset Management Inc. Buys 228 Shares of DaVita Inc. (NYSE:DVA)

iA Global Asset Management Inc. grew its stake in DaVita Inc. (NYSE:DVA) by 5.8% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,158 shares of the company’s stock after acquiring an additional 228 shares during the period. iA Global Asset Management Inc.’s holdings in DaVita were worth $576,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the stock. 8 Knots Management LLC bought a new position in DaVita in the fourth quarter worth approximately $89,504,000. Doma Perpetual Capital Management LLC bought a new position in shares of DaVita during the 4th quarter worth $53,076,000. Norges Bank purchased a new position in shares of DaVita during the fourth quarter valued at $36,626,000. Allianz Asset Management GmbH raised its holdings in shares of DaVita by 63.9% in the fourth quarter. Allianz Asset Management GmbH now owns 548,642 shares of the company’s stock valued at $57,476,000 after acquiring an additional 213,992 shares in the last quarter. Finally, Pinebridge Investments L.P. raised its holdings in shares of DaVita by 148.8% in the fourth quarter. Pinebridge Investments L.P. now owns 268,601 shares of the company’s stock valued at $28,139,000 after acquiring an additional 160,630 shares in the last quarter. 90.12% of the stock is owned by hedge funds and other institutional investors.

DaVita Stock Down 1.5 %

Shares of DVA stock opened at $150.92 on Friday. DaVita Inc. has a fifty-two week low of $71.51 and a fifty-two week high of $156.44. The firm has a market capitalization of $13.24 billion, a PE ratio of 17.15, a P/E/G ratio of 0.89 and a beta of 0.87. The company has a debt-to-equity ratio of 9.94, a quick ratio of 1.12 and a current ratio of 1.16. The stock’s 50-day simple moving average is $142.50 and its 200-day simple moving average is $137.65.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $2.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.47 by $0.12. The company had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.15 billion. DaVita had a net margin of 6.86% and a return on equity of 77.00%. DaVita’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same period last year, the firm posted $2.08 EPS. Equities analysts expect that DaVita Inc. will post 9.99 earnings per share for the current year.

Insider Activity at DaVita

In other news, insider Kathleen Alyce Waters sold 7,857 shares of the firm’s stock in a transaction that occurred on Tuesday, August 13th. The shares were sold at an average price of $146.21, for a total transaction of $1,148,771.97. Following the sale, the insider now owns 83,011 shares of the company’s stock, valued at approximately $12,137,038.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other DaVita news, CEO Javier Rodriguez sold 32,176 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $155.93, for a total value of $5,017,203.68. Following the sale, the chief executive officer now directly owns 905,659 shares of the company’s stock, valued at $141,219,407.87. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Kathleen Alyce Waters sold 7,857 shares of the company’s stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $146.21, for a total value of $1,148,771.97. Following the transaction, the insider now directly owns 83,011 shares of the company’s stock, valued at $12,137,038.31. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 113,601 shares of company stock worth $17,525,449. 2.00% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

DVA has been the topic of a number of research reports. TD Cowen raised their target price on shares of DaVita from $139.00 to $150.00 and gave the company a “hold” rating in a research report on Wednesday, July 24th. UBS Group upped their price objective on DaVita from $169.00 to $175.00 and gave the stock a “buy” rating in a research note on Thursday, August 8th. Barclays upped their target price on DaVita from $133.00 to $150.00 and gave the company an “equal weight” rating in a research report on Monday, May 6th. Truist Financial raised their price target on DaVita from $150.00 to $165.00 and gave the stock a “hold” rating in a report on Tuesday, August 20th. Finally, Bank of America upped their price objective on shares of DaVita from $139.00 to $145.00 and gave the company an “underperform” rating in a report on Wednesday, August 7th. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $157.00.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.